Boothbay Fund Management, LLC Praxis Precision Medicines, Inc. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.87 - $1.71 $394,240 - $774,886	453,150 New	453,150 $774,000
Q1 2023 May 15, 2023	BUY	$0.8 - $4.98 $36,546 - $227,501	45,683 Added 178.73%	71,243 $57,000
Q4 2022 Feb 14, 2023	BUY	$1.88 - $36.45 $48,052 - $931,662	25,560 New	25,560 $60,000
Q4 2021 Feb 14, 2022	SELL	$16.76 - $22.99 $182,013 - $249,671	-10,860 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.15 - $22.56 $142,809 - $245,001	10,860 New	10,860 $201,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.